Bernard Milleron

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Olivier Molinier, Franck Morin, Christian Creveuil, 2016, The Lancet.

Impact of Computed Tomography and 18F-Deoxyglucose-Hybrid Positron Emission Tomography Image Fusion on Conformal Radiotherapy in Non-Small Cell Lung Cancer

H. El Balaa, E. Touboul, Khaldoun Kerrou, 2005 .

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Antoine Flahault, Catherine Beigelman-Aubry, Yves Martinet, 2007, Lung cancer.

Lung cancer screening: what is new since the NLST results?

Sébastien Couraud, B. Milleron, S. Couraud, 2016, Current Pulmonology Reports.

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Jean Mosser, Franck Morin, Gérard Zalcman, 2016, The Lancet.

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

Hanna El Balaa, Jean-Noël Talbot, E. Touboul, 2005, International journal of radiation oncology, biology, physics.

Lung cancer in never smokers--a review.

Sébastien Couraud, Franck Morin, Gérard Zalcman, 2012, European journal of cancer.